Valuation: Tsumura & Co.

Market Cap 281B 1.78B 1.54B 1.44B 1.32B 2.48B 170B 2.52B 16.89B 6.63B 85.03B 6.69B 6.55B P/E 2027 *
10.8x
P/E 2028 * 10.4x
Enterprise Value 378B 2.4B 2.07B 1.94B 1.78B 3.34B 228B 3.4B 22.73B 8.92B 114B 9B 8.81B EV / Sales 2027 *
1.74x
EV / Sales 2028 * 1.83x
Free-Float
90.5%
Yield 2027 *
4.19%
Yield 2028 * 4.58%
1 day+0.21%
1 week-4.19%
Current month-1.21%
1 month-0.61%
3 months+3.88%
6 months-10.13%
Current year-7.51%
1 week 3,702
Extreme 3702
3,809
1 month 3,702
Extreme 3702
4,079
Current year 3,513
Extreme 3513
4,403
1 year 3,444
Extreme 3444
4,403
3 years 2,570
Extreme 2570
5,138
5 years 2,536
Extreme 2536
5,138
10 years 2,189
Extreme 2189
5,138
Manager TitleAgeSince
Chief Executive Officer 63 2019-05-31
Director of Finance/CFO - -
Chief Operating Officer 56 2022-03-31
Director TitleAgeSince
Director/Board Member 63 2011-05-31
Director/Board Member 77 2018-05-31
Director/Board Member 70 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.21%-4.19%+6.08%+45.74% 1.77B
-0.52%+2.66%+58.86%+163.79% 1,062B
+0.88%+1.34%+51.97%+53.36% 619B
+0.89%-4.42%+25.34%+66.55% 431B
+0.71%+3.93%+47.75%+38.58% 358B
+0.64%-0.63%+36.39%+41.44% 293B
+0.39%-6.48%+7.62%+9.04% 247B
+1.51%+6.01%+44.36%+68.92% 219B
+3.92%-7.80%+5.39%-42.52% 200B
+1.80%+1.47%+20.79%+69.31% 162B
Average +1.20%-1.47%+30.45%+51.42% 359.41B
Weighted average by Cap. +1.12%+0.16%+41.58%+78.42%

Financials

2027 *2028 *
Net sales 217B 1.37B 1.19B 1.11B 1.02B 1.92B 131B 1.95B 13.03B 5.11B 65.57B 5.16B 5.05B 229B 1.45B 1.26B 1.17B 1.08B 2.02B 138B 2.06B 13.77B 5.4B 69.29B 5.45B 5.34B
Net income 26.04B 165M 143M 133M 122M 230M 15.72B 234M 1.57B 614M 7.88B 620M 607M 26.96B 171M 148M 138M 127M 238M 16.27B 242M 1.62B 636M 8.16B 642M 628M
Net Debt 97.06B 615M 532M 497M 456M 858M 58.57B 871M 5.83B 2.29B 29.36B 2.31B 2.26B 138B 878M 759M 709M 650M 1.22B 83.53B 1.24B 8.32B 3.26B 41.87B 3.3B 3.22B
Logo Tsumura & Co.
Tsumura & Co is a Japan-based company mainly engaged in manufacturing and sales of prescription drugs and over-the-counter drugs. The Company operates the Pharmaceuticals segment. In Japan, the Company conducts the manufacturing, sales, transportation and storage of prescription drugs and over-the-counter drugs, and cultivation, procurement, selection, processing and storage of raw medicinal herbs. In China, the Company is engaged in regional management, business management, production and sales of herbal extract powders, cultivation, procurement, selection, processing and storage of herbal ingredients, and sales of pharmaceuticals and food products. In Laos, the Company is engaged in cultivation, procurement, selection, processing and storage of herbal ingredients. In the United States, the Company is engaged in pharmaceutical development business.
Employees
4,923
Date Price Change Volume
26-08-07 JP¥3,771.00 +0.21% 487,500
26-08-06 JP¥3,763.00 +1.32% 521,500
26-08-05 JP¥3,714.00 -1.41% 382,400
26-08-04 JP¥3,767.00 -0.61% 253,200
26-08-03 JP¥3,790.00 -0.71% 477,800
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
3,771.00JPY
Average target price
4,400.00JPY
Spread / Average Target
+16.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4540 Stock